# Nippon Kayaku Pharmatech Co., Ltd. – FDA Inspection, Sep 4, 2026

Source: https://www.keypedia.com/records/fda_inspections/nippon-kayaku-pharmatech-co-ltd/77bf1560-ef7b-4938-a61e-dbd109da0aef
Source feed: FDA_Inspections

> FDA inspection 1335048 of Nippon Kayaku Pharmatech Co., Ltd., September 04, 2026. 5 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1335048
- Company Name: Nippon Kayaku Pharmatech Co., Ltd.
- Inspection Date: 2026-09-04
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 5

## Related Documents

- [FDA Inspection 1192063 - 2022-11-25](https://www.keypedia.com/records/fda_inspections/nippon-kayaku-pharmatech-co-ltd/7595fc4c-3ff0-4fc0-b834-27f05930500e)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)

Company: https://www.keypedia.com/companies/nippon-kayaku-pharmatech-co-ltd/88530942-e172-4a65-8c32-4495fdaa6b61

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8